Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clarity Pharmaceuticals Ltd. (AU:CU6)
ASX:CU6
RESEARCH TOOLSreports
Holding AU:CU6?
Track your performance easily
CU6 Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$1.42 - AU$8.98
Previous CloseAU$6.41
Volume140.65K
Average Volume (3M)1.81M
Market Cap
AU$2.05B
Enterprise ValueAU$1.96B
Total Cash (Recent Filing)AU$92.34M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Feb 26, 2025EPS Estimate
-AU$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares OutstandingN/A
10 Day Avg. Volume1,081,162
30 Day Avg. Volume1,805,409
Standard Deviation0.21
R-Squared0.09
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$8.48Price Target Upside43.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Clarity Pharmaceuticals Ltd. News
PremiumCompany Announcements
Clarity Pharmaceuticals Advances Radiopharmaceutical Diagnostics
PremiumCompany Announcements
Clarity Pharmaceuticals Launches Promising Prostate Cancer Trial
PremiumCompany Announcements
Clarity Pharmaceuticals Director Increases Stock Options
PremiumCompany Announcements
Clarity Pharmaceuticals Issues New Equity Options
PremiumCompany Announcements
Clarity Pharmaceuticals Reports Successful AGM Resolutions
PremiumCompany Announcements
Clarity Pharmaceuticals Advances in Radiopharmaceutical InnovationsPremiumCompany Announcements
Clarity Pharmaceuticals Shares Business Insights Amidst Market Data
PremiumCompany Announcements
Clarity Pharmaceuticals Launches Promising Prostate Cancer TrialOptions Prices
Currently, No data available
---
Ownership Overview
13.06% Insiders
0.86% Mutual Funds
― Other Institutional Investors
83.87% Public Companies and
Individual Investors
CU6 FAQ
What was Clarity Pharmaceuticals Ltd.’s price range in the past 12 months?
Clarity Pharmaceuticals Ltd. lowest share price was AU$1.42 and its highest was AU$8.97 in the past 12 months.
What is Clarity Pharmaceuticals Ltd.’s market cap?
Currently, no data Available
When is Clarity Pharmaceuticals Ltd.’s upcoming earnings report date?
Clarity Pharmaceuticals Ltd.’s upcoming earnings report date is Feb 26, 2025 which is in 85 days.
How were Clarity Pharmaceuticals Ltd.’s earnings last quarter?
Clarity Pharmaceuticals Ltd. released its earnings results on Aug 23, 2024. The company reported -AU$0.059 earnings per share for the quarter, missing the consensus estimate of -AU$0.052 by -AU$0.007.
Is Clarity Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Clarity Pharmaceuticals Ltd.’s price is currently Undervalued.
Does Clarity Pharmaceuticals Ltd. pay dividends?
Clarity Pharmaceuticals Ltd. does not currently pay dividends.
What is Clarity Pharmaceuticals Ltd.’s EPS estimate?
Clarity Pharmaceuticals Ltd.’s EPS estimate is -AU$0.07.
How many shares outstanding does Clarity Pharmaceuticals Ltd. have?
Clarity Pharmaceuticals Ltd. has 320,211,460 shares outstanding.
What happened to Clarity Pharmaceuticals Ltd.’s price movement after its last earnings report?
Clarity Pharmaceuticals Ltd. reported an EPS of -AU$0.059 in its last earnings report, missing expectations of -AU$0.052. Following the earnings report the stock price went down -2.467%.
Which hedge fund is a major shareholder of Clarity Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:CU6
---
Clarity Pharmaceuticals Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$8.48 (43.00% Upside)
AU$8.48 (43.00% Upside)
Blogger Sentiment
Bullish
AU:CU6 Sentiment 94%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
343.54%
12-Months-Change
Fundamentals
Return on Equity
-39.29%
Trailing 12-Months
Asset Growth
101.09%
Trailing 12-Months
Company Description
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.
---
CU6 Stock 12 Month Forecast
Average Price Target
AU$8.48
▲(43.00% Upside)
Technical Analysis
Race Oncology Ltd.
―
Cyclopharm Limited
―
Proteomics International Laboratories Ltd.
―
Alcidion Group Limited
―
Best Analysts Covering CU6
1 Year
1 Year Success Rate
6/7 ratings generated profit
1 Year Average Return
+133.74%
reiterated a buy rating 4 months ago
Copying John Hester's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +133.74% per trade.
---